| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2551045 | Life Sciences | 2014 | 6 Pages |
Abstract
This study provides advanced information for developing strategies using recombinant TAT-fused ITF proteins in place of adenoviral vectors for the conversion of pancreatic exocrine cells into insulin-positive cells for the treatment of diabetes.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Michael S. Lan, Chiachen Chen, Nicolle A. Saunee, Tao Zhang, Mary B. Breslin,